The global challenge of new classes of antibacterial agents: an industry perspective.

Abstract

With rising antibiotic resistance and the fear of returning to the pre-penicillin era, incentives are being provided for developing novel antibiotics. The hurdles faced by antibiotic developers include the difficulty in discovering novel chemicals that have selectivity and the increased regulatory scrutiny for safety and efficacy. Furthermore, the… (More)
DOI: 10.1016/j.coph.2015.06.003

Topics

Cite this paper

@article{Fernandes2015TheGC, title={The global challenge of new classes of antibacterial agents: an industry perspective.}, author={Prabhavathi B. Fernandes}, journal={Current opinion in pharmacology}, year={2015}, volume={24}, pages={7-11} }